Is SILO research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SILO. It does not provide personalized investment advice.

SILO (Silo Pharma, Inc. Common Stock) Stock Analysis - Financials

Silo Pharma, Inc. Common Stock (SILO) is a publicly traded Healthcare sector company. As of July 7, 2026, SILO trades at $6.11 with a market cap of $6.97M and a P/E ratio of -12.52. SILO moved +1.29% today. Year to date, SILO is +18.48%; over the trailing twelve months it is -32.64%. Its 52-week range spans $3.32 to $50.55. Rallies surfaces SILO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are SILO's key financials?

SILO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SILO recently traded at $6.11. Market cap is $6.97M. P/E ratio is -12.52. Revenue is $72.10K.

SILO Key Metrics

Key financial metrics for SILO
Metric	Value
Price	$6.11
Market Cap	$6.97M
P/E Ratio	-12.52
EPS	$-0.50
Dividend Yield	0.00%
52-Week High	$50.55
52-Week Low	$3.32
Volume	120.51K
Avg Volume	0
Revenue (TTM)	$72.10K
Net Income	$-4.23M
Gross Margin	38.57%

SILO Analyst Consensus

SILO analyst coverage data. Average price target: $0.00.

Common questions about SILO

What are SILO's key financials?: SILO financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. SILO recently traded at $6.11. Market cap is $6.97M. P/E ratio is -12.52. Revenue is $72.10K.
Is SILO research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SILO. It does not provide personalized investment advice.